You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (7) |
Back to Search
Enhanced growth inhibition and apoptosis of human breast cancer by combination therapy of teta and carboplatin
- In: SIG Pharmaceutical Biotechnology - Posters
- At: Beijing (China) (2007)
- Type: Poster
- Poster code: PB-P-012
- By: GUO, Lixia (Technology and Business University, Chongqing, China)
- Co-author(s): Liu, Jianhui (Technology and Business University, CHONGQING, China)
Chen, Gang (Technology and Business University, CHONGQING, China)
Deng, Xiaohong (Technology and Business University, CHONGQING, China) - Abstract:
OBJECTIVE To study the synergistic effect of Triethylene tetraamine （TETA） and carboplatin on MCF-7 cells apoptosis. METHODS MCF-7 was cultured in vitro, and incubated with different concentrations of TETA and carboplatin respectively or jointly. The inhibition of MCF-7 cells was determined by SRB, the apoptosis was evaluated using the..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026